-+ 0.00%
-+ 0.00%
-+ 0.00%

60 Degrees Pharmaceuticals Launches B-Free Study to Evaluate Tafenoquine for Chronic Babesiosis Fatigue

Reuters·12/29/2025 13:01:11

Please log in to view news